FormulationX To Debut At INTERPHEX 2018

International Pharmaceutical Expo  the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialization, today announced FormulationX will debut at INTERPHEX 2018 featuring exhibits, technical conference and networking focused on drug substance.

Elsevier, a leading information analytics company specializing in science and health, will serve as a Foundation Sponsor of FormulationX. Elsevier is a long-established organization that is widely recognized as a key resource in helping progress science, advance healthcare and improve performance. The collaboration aligns with the goals of both organizations to offer first-hand access to the very latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle. INTERPHEX will take place April 17-19, 2018 at the Javits Center, New York, NY.

“FormulationX was designed to meet the needs of the North American market and drug substance industry professionals,” explained Melissa Ashley, Senior Vice President, INTERPHEX. “Pharmaceutical and biotechnology companies’ around the world expect an increase in spend for raw materials, excipients, intermediates, fine chemicals and API in the coming years due to the increasing demand for new drugs, innovation in excipients and new technologies used in manufacturing.”

Ashley continued, “Increasing the presence of drug substance suppliers catering to the needs of targeted attendee groups will further strengthen the value proposition of INTERPHEX offering an even more robust platform of formulation through commercialization technologies, products and services. With the debut of FormulationX, INTERPHEX is well-positioned to continue its leadership role in delivering value to our customers and access to a full-range of technologies and industry expertise to address challenges faced by the industries we serve.”

“Our Foundation Sponsor designation in support of INTERPHEX underscores our commitment to help the research community make discoveries, collaborate with industry colleagues and share insight, expanding the boundaries of knowledge and intelligence for the benefit of humanity,” said Tim Hoctor, Vice President of Professional Services, Elsevier. “We believe personalized technology is helping researchers accelerate their research and make unanticipated connections, which is particularly important as the body of knowledge and data continues to grow rapidly. INTERPHEX provides the ideal platform to for these connections to happen via a strong technical learning program.”

Located within INTERPHEX 2018, FormulationX offers an opportunity to meet, network and share expertise in a dedicated space featuring exhibitors and a no cost technical conference program specific to drug substance. Companies interested in exhibiting at the first annual FormulationX should visit www.formulation-x.com to view available space selections and contact Mike Putnam at mputnam@reedexpo.com or 203.840.5596.

Registration for INTERPHEX and FormulationX is now open.

About Elsevier
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray’s Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

About INTERPHEX
For the past 38 years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization.” Sponsored by the Parenteral Drug Association (PDA), the event is based in New York and brings over 11,000 global industry professionals and 630+ industry leading suppliers together to “Learn it, Experience it, Procure it” through a unique combination of no cost technical conference, exhibits, demonstrations, roundtables, partnering opportunities and networking to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. Follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and Twitter. IPX Blogcontinues the learning beyond the show floor.

Contact:
Pia Jensen
Spark Communications
Tel: 020 7436 0420
Email: pia@sparkcomms.co.uk
Twitter: @sparkcomms
Website: www.sparkcomms.co.uk